MA53636A - Agent de traitement de troubles dermatologiques - Google Patents
Agent de traitement de troubles dermatologiquesInfo
- Publication number
- MA53636A MA53636A MA053636A MA53636A MA53636A MA 53636 A MA53636 A MA 53636A MA 053636 A MA053636 A MA 053636A MA 53636 A MA53636 A MA 53636A MA 53636 A MA53636 A MA 53636A
- Authority
- MA
- Morocco
- Prior art keywords
- agent
- treatment
- dermatological disorders
- dermatological
- disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/48—Nerve growth factor [NGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Psychology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18194930 | 2018-09-17 | ||
| EP18203665 | 2018-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA53636A true MA53636A (fr) | 2021-12-22 |
Family
ID=67989007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA053636A MA53636A (fr) | 2018-09-17 | 2019-09-17 | Agent de traitement de troubles dermatologiques |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20220064243A1 (https=) |
| EP (1) | EP3852785A1 (https=) |
| JP (2) | JP2022502359A (https=) |
| KR (1) | KR20210061388A (https=) |
| CN (1) | CN113226350B (https=) |
| AU (1) | AU2019343514B2 (https=) |
| BR (1) | BR112021003820A2 (https=) |
| CA (1) | CA3111158A1 (https=) |
| MA (1) | MA53636A (https=) |
| MX (1) | MX2021002983A (https=) |
| WO (1) | WO2020058217A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023536229A (ja) * | 2020-07-27 | 2023-08-24 | ヒューマン セル カンパニー | Ｎｇｆバリアント、産生、組成物、及び治療的使用 |
| CA3207296A1 (en) * | 2021-01-06 | 2022-07-14 | The Penn State Research Foundation | Methods and materials for treating hair loss |
| US12268677B2 (en) | 2022-04-27 | 2025-04-08 | The Penn State Research Foundation | 4-aminopyridine (4-AP) and bone morphogenetic protein 2 (BMP-2) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2213861T3 (es) | 1998-10-09 | 2004-09-01 | Scil Proteins Gmbh | Procedimiento de obtencion de ngf-beta activa. |
| EP1482966B1 (en) | 2002-03-12 | 2014-05-14 | Bio-Click Technologies Ltd | Method and composition for treating skin wounds with epidermal growth factor |
| ITRM20060367A1 (it) * | 2006-07-13 | 2008-01-14 | Lay Line Genomics Spa | Muteine del hngf usi terapeutici e composizioni farmaceutiche |
| WO2010128519A1 (en) | 2009-05-04 | 2010-11-11 | Kumar C Jairaj | A method for detecting neuropathy and predicting foot ulcer development in human beings with health conditions like diabetes mellitus |
| CN104203264B (zh) | 2011-12-19 | 2018-08-28 | 瓦克化学有限公司 | 新型proNGF突变体及其在生产β-NGF中的用途 |
| US20180086805A1 (en) * | 2016-05-20 | 2018-03-29 | Chiesi Farmaceutici S.P.A. | proNGF mutants and uses thereof for the preparation of NGF mutants |
-
2019
- 2019-09-17 JP JP2021514556A patent/JP2022502359A/ja active Pending
- 2019-09-17 CA CA3111158A patent/CA3111158A1/en active Pending
- 2019-09-17 KR KR1020217011307A patent/KR20210061388A/ko not_active Ceased
- 2019-09-17 BR BR112021003820-5A patent/BR112021003820A2/pt unknown
- 2019-09-17 CN CN201980060757.0A patent/CN113226350B/zh active Active
- 2019-09-17 MA MA053636A patent/MA53636A/fr unknown
- 2019-09-17 WO PCT/EP2019/074767 patent/WO2020058217A1/en not_active Ceased
- 2019-09-17 MX MX2021002983A patent/MX2021002983A/es unknown
- 2019-09-17 US US17/277,240 patent/US20220064243A1/en not_active Abandoned
- 2019-09-17 AU AU2019343514A patent/AU2019343514B2/en active Active
- 2019-09-17 EP EP19769794.9A patent/EP3852785A1/en active Pending
-
2025
- 2025-03-28 US US19/093,959 patent/US20250277010A1/en active Pending
- 2025-05-07 JP JP2025077313A patent/JP2025125558A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022502359A (ja) | 2022-01-11 |
| BR112021003820A2 (pt) | 2021-05-25 |
| AU2019343514A1 (en) | 2021-04-15 |
| CA3111158A1 (en) | 2020-03-26 |
| EP3852785A1 (en) | 2021-07-28 |
| JP2025125558A (ja) | 2025-08-27 |
| KR20210061388A (ko) | 2021-05-27 |
| AU2019343514B2 (en) | 2025-09-25 |
| CN113226350B (zh) | 2024-09-10 |
| MX2021002983A (es) | 2021-05-14 |
| WO2020058217A1 (en) | 2020-03-26 |
| US20220064243A1 (en) | 2022-03-03 |
| CN113226350A (zh) | 2021-08-06 |
| US20250277010A1 (en) | 2025-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3731772T3 (da) | Systems for the treatment of disease states and disorders | |
| EP3704108A4 (en) | COMPOUNDS AND COMPOSITIONS FOR TREATMENT OF HEMATOLOGICAL DISORDERS | |
| EP3448398A4 (en) | COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES | |
| EP3481387A4 (en) | METHOD AND COMPOSITIONS FOR TREATING EPILEPTIC DISEASES | |
| MA45481A (fr) | Utilisation d'exosomes pour le traitement de maladies | |
| EP3328492A4 (en) | PHOTOTHERAPY DEVICES FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS OF THE HEADACHE | |
| EP3448875A4 (en) | COMPOSITIONS FOR TREATING A DISEASE | |
| EP3448987A4 (en) | COMPOSITIONS FOR TREATING A DISEASE | |
| IL288001A (en) | Compounds for the treatment of neurodegenerative and metabolic disorders | |
| EP3411380A4 (en) | Compounds for treating eye disorders or diseases | |
| EP4045037C0 (en) | HETEROARYL-BIPHENYL-AMINE FOR THE TREATMENT OF PD-L1 DISEASES | |
| IL286340A (en) | Topical formulations for treatment of peripheral neuropathies | |
| MA44875A (fr) | Compositions pour le traitement de troubles acido-basiques | |
| EP3328864A4 (en) | THERAPEUTIC COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF SOCIAL DISORDERS AND DRUG ABUSE | |
| EP3352749A4 (en) | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES | |
| EP3445352A4 (en) | COMPOSITIONS FOR THE TREATMENT OF HYPERKERATOSIS DISEASES | |
| EP3400061A4 (en) | LIGHT THERAPY SYSTEM FOR THE TREATMENT OF NASAL DISEASES | |
| MA51672A (fr) | Composés destinés au traitement des troubles kinases-dépendants | |
| EP3606520A4 (en) | INHIBITORS OF SHORT CHAIN DEHYDROGENASE ACTIVITY FOR THE TREATMENT OF CORONARY DISEASES | |
| MA47207A (fr) | Composés utiles pour le traitement de troubles du tractus digestif | |
| EP3672587A4 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES | |
| EP3766497A4 (en) | Drug for treating cough | |
| EP3481958A4 (en) | METHOD AND COMPOSITIONS FOR TREATING DISTURBANCES AND DISEASES WITH RDH12 | |
| MA49140A (fr) | Composés hétéroaromatiques-aniline fusionnés pour le traitement de troubles dermiques | |
| MA54077A (fr) | Polythérapie pour le traitement de maladies hématologiques |